Sun Pharma gains on launching Gemcitabine InfuSMART in Europe

11 Jul 2016 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 785.25, up by 6.70 points or 0.86% from its previous closing of Rs. 778.55 on the BSE.

The scrip opened at Rs. 791.00 and has touched a high and low of Rs. 791.00 and Rs. 785.25 respectively. So far 4,795 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 965.15 on 20-Aug-2015 and a 52 week low of Rs. 706.40 on 24-Nov-2015.

Last one week high and low of the scrip stood at Rs. 791.00 and Rs. 764.65 respectively. The current market cap of the company is Rs. 1,88,805.00 crore.

The promoters holding in the company stood at 54.97%, while Institutions and Non-Institutions held 35.37% and 9.66% respectively.

Sun Pharmaceutical Industries has rolled-out Gemcitabine InfuSMART in Europe. InfuSMART is a technology in which oncology products are developed in a Ready-To-Administer (RTA) bag. Until now, compounding of oncology products was done at compounding centres or compounded in hospital pharmacies, an extra step before the medicine can be administered to patients.

With the roll-out of Gemcitabine InfuSMART, the pharma major becomes world’s first pharmaceutical company to manufacture and launch a licensed RTA oncology product. This innovatively differentiated product will have a shelf life of two years. Over the next few months, Sun Pharma will launch Gemcitabine InfuSMART across Netherlands, UK, Spain, Germany, Italy & France.

Sun Pharma received regulatory approval to produce Gemcitabine InfuSMART in eight key SKUs. The InfuSMART concept involves dose banding practice whereby, through agreement between prescribers and pharmacists, standardized doses of intravenous cytotoxic drugs are used for ranges (or bands) of doses calculated for individual patients. More InfuSMART oncology products are currently in Sun Pharma’s pipeline to be rolled out in the future. 


Sun Pharma Inds. Share Price

1669.20 -31.35 (-1.84%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×